Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Feb 16;13(2):357-365.
doi: 10.1021/acschembio.7b00855. Epub 2017 Dec 20.

Type II-C CRISPR-Cas9 Biology, Mechanism, and Application

Affiliations
Review

Type II-C CRISPR-Cas9 Biology, Mechanism, and Application

Aamir Mir et al. ACS Chem Biol. .

Abstract

Genome editing technologies have been revolutionized by the discovery of prokaryotic RNA-guided defense system called CRISPR-Cas. Cas9, a single effector protein found in type II CRISPR systems, has been at the heart of this genome editing revolution. Nearly half of the Cas9s discovered so far belong to the type II-C subtype but have not been explored extensively. Type II-C CRISPR-Cas systems are the simplest of the type II systems, employing only three Cas proteins. Cas9s are central players in type II-C systems since they function in multiple steps of the CRISPR pathway, including adaptation and interference. Type II-C CRISPR systems are found in bacteria and archaea from very diverse environments, resulting in Cas9s with unique and potentially useful properties. Certain type II-C Cas9s possess unusually long PAMs, function in unique conditions (e.g., elevated temperature), and tend to be smaller in size. Here, we review the biology, mechanism, and applications of the type II-C CRISPR systems with particular emphasis on their Cas9s.

PubMed Disclaimer

Conflict of interest statement

Notes

The authors declare the following competing financial interest(s): E.J.S. is a co-founder and scientific advisor of Intellia Therapeutics. Northwestern University and the University of Massachusetts Medical School have patents pending for CRISPR technologies of which E.J.S. is an inventor.

Figures

Figure 1
Figure 1
Characteristics of type II-C CRISPR-Cas systems. (A) A typical type II-C CRISPR locus contains a tracrRNA, three cas genes, and the CRISPR array. The spacer sequences in the array are depicted as diamonds, repeat sequences are shown as squares, and the internal promoters are shown as arrows. (B) The domain architecture of type II-C Cas9s. The individual domains are colored separately and labeled. (C) A phylogenetic tree of in vitro validated type II-C Cas9s. The reported PAMs and the protein sizes of Cas9s are also listed. Cas9s validated for mammalian editing are also marked as Y (Yes) or N (No).
Figure 2
Figure 2
Structures of representative type II-C Cas9s and their sgRNAs. (A) The predicted secondary structures of sgRNAs from NmeCas9, GeoCas9, and CjeCas9 are shown. Secondary structures were predicted using mFold. The secondary structure of CjeCas9 as seen in the crystal structure is also shown. (B) From left to right: crystal structures of CjeCas9:sgRNA:DNA, apo AnaCas9, and overlay of CjeCas9 and AnaCas9. The individual domains are colored and are labelled separately. The structures are depicted as cartoons, and were rendered in PyMol using coordinates from pdb entries 4OGE and 5X2H.

Similar articles

Cited by

References

    1. Marraffini LA. CRISPR-Cas immunity in prokaryotes. Nature. 2015;526:55–61. - PubMed
    1. Mohanraju P, Makarova KS, Zetsche B, Zhang F, Koonin EV, van der Oost J. Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems. Science. 2016;353:aad5147. - PubMed
    1. Shipman SL, Nivala J, Macklis JD, Church GM. CRISPR-Cas encoding of a digital movie into the genomes of a population of living bacteria. Nature. 2017;547:345–349. - PMC - PubMed
    1. Barrangou R, Doudna JA. Applications of CRISPR technologies in research and beyond. Nature biotechnology. 2016;34:933–941. - PubMed
    1. Komor AC, Badran AH, Liu DR. CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes. Cell. 2017;168:20–36. - PMC - PubMed

Publication types

MeSH terms